• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events

LMB In The News

Andrew Beale announced a Public Outreach Fellow for the Society for Research on Biological Rhythms

Published on 6 July, 2022

Andrew Beale, a postdoc in John O’Neill’s group in the LMB’s Cell Biology Division, discusses his plans as new Public Outreach Fellow for the Society for Research on Biological Rhythms (SRBR), how a serendipitous lab visit during his PhD got him hooked on circadian rhythms and his hobbies when he’s away from work. More…

Greg Winter on innovation in science, his research on phage display and its therapeutic impact, and winning the Nobel Prize

Published on 30 June, 2022

Roger Highfield, Science Director at the Science Museum, speaks to the LMB’s Greg Winter about his earliest scientific memories, how a road rage attack redirected his research to focus on protein engineering of antibodies and the day he found out he’d won the Nobel Prize in Chemistry. More…

Redefining human brain temperature and its clinical utility

Published on 27 June, 2022

Magnetic resonance spectroscopy allowed Nina Rzechorzek (member of the O’Neill group, Cell Biology) and collaborators to create a HEATWAVE map, showing how temperatures vary in the brain across the day, between the sexes, and as we age – a healthy brain is remarkably hotter than previously assumed. More…

Michel Goedert discusses his life and career in research with DZNE

Published on 16 May, 2022

To mark the award of the Hartwig Piepenbrock-DZNE Prize for his ground-breaking research into the molecular basis of neurodegenerative diseases, DZNE have released a video portrait of Michel Goedert, Group Leader in the LMB’s Neurobiology Division. More…

LMB in vitro testing highlights bicyclic peptides (Bicycle®) as potential antiviral compounds against SARS-CoV-2

Published on 28 April, 2022

Bicycle Therapeutics reports on its updated preclinical data produced in collaboration with Leo James’ group in the LMB’s PNAC Division. In vitro tests of their proprietary bicyclic peptide show promise for antiviral modality against SARS-CoV-2. More…

LMB research featured in summary of three cryo-EM studies of TMEM106b fibrils found in neurodegenerative diseases

Published on 13 April, 2022

Alzforum summarises three recent papers which analysed TMEM106b amyloid filaments in the human brain – including research from Sjors Scheres’ and Michel Goedert’s groups in the LMB’s Structural Studies and Neurobiology Divisions respectively. More…

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Interim pages omitted …
  • Page 89
  • Go to Next Page »

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed. Ok